Under the new partnership, Lupin will distribute and market Lilly#39;s Aplevant (dulaglutide), once a weekly injection for type 2 diabetes treatment, Lupin said in a regulatory filing.from Moneycontrol Business News https://ift.tt/2DKtL53
Monday, October 1, 2018
Lupin inks pact to distribute Eli Lilly#39;s diabetes injection in India
Under the new partnership, Lupin will distribute and market Lilly#39;s Aplevant (dulaglutide), once a weekly injection for type 2 diabetes treatment, Lupin said in a regulatory filing.from Moneycontrol Business News https://ift.tt/2DKtL53
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
In a regulatory filing the company said the Odisha Electricity Regulatory Commission (OERC) has awarded the Letter of Intent (LOI) to Tata ...
No comments:
Post a Comment